State of Alaska Department of Revenue Lowers Position in Intuitive Surgical, Inc. $ISRG

Key Points

• State of Alaska Department of Revenue reduced its ISRG stake by 8.3% in Q4, now owning 35,100 shares valued at $19.88 million after selling 3,170 shares.
• Insiders have sold 32,943 shares over the past 90 days (≈$17.28 million), leaving insiders with just 0.60% ownership.
• Institutional investors own 83.64% of ISRG; analysts maintain a consensus "Moderate Buy" with a $607 target even as the stock is down roughly 20% YTD and trades at a P/E near 57.12.

State of Alaska Department of Revenue lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 8.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 35,100 shares of the medical equipment provider's stock after selling 3,170 shares during the quarter. State of Alaska Department of Revenue's holdings in Intuitive Surgical were worth $19,879,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. lifted its stake in shares of Intuitive Surgical by 0.8% in the 3rd quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider's stock valued at $15,026,776,000 after purchasing an additional 263,828 shares during the period. Capital World Investors raised its stake in Intuitive Surgical by 1.5% during the third quarter. Capital World Investors now owns 7,728,492 shares of the medical equipment provider's stock valued at $3,456,223,000 after buying an additional 116,034 shares during the last quarter. Fisher Asset Management LLC raised its stake in Intuitive Surgical by 1.1% during the third quarter. Fisher Asset Management LLC now owns 3,889,439 shares of the medical equipment provider's stock valued at $1,739,475,000 after buying an additional 40,702 shares during the last quarter. Amundi raised its stake in Intuitive Surgical by 29.7% during the third quarter. Amundi now owns 3,227,472 shares of the medical equipment provider's stock valued at $1,451,362,000 after buying an additional 739,444 shares during the last quarter. Finally, Legal & General Group Plc raised its stake in Intuitive Surgical by 6.3% during the third quarter. Legal & General Group Plc now owns 2,376,714 shares of the medical equipment provider's stock valued at $1,062,938,000 after buying an additional 141,357 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: BTIG reaffirmed a "buy" on ISRG and set a $616 price target (~36.7% above the recent price), giving investors a clear upside thesis tied to continued procedure growth and platform expansion. BTIG research note
• Positive Sentiment: Hedge-fund veteran Israel Englander has been increasing exposure to ISRG, signaling conviction from a long-term institutional holder and potentially supporting demand for the shares. Intuitive Surgical Inc. (ISRG): Israel Englander Is Loading Up on This Stock
• Positive Sentiment: Company commentary and analyst notes emphasize reaffirmed double-digit da Vinci procedure growth guidance and investment in new platforms (like Ion), which underpin recurring revenue from instruments & services and longer-term margin expansion. Reaffirmed da Vinci Growth Guidance and New Platforms Could Be A Game Changer For Intuitive Surgical (ISRG)
• Neutral Sentiment: Analysts highlight 13–15% procedure growth forecast for 2026 — a sign of durable demand — but warn that macro or policy shifts could pressure ISRG’s premium valuation. This is supportive long term but creates debate over near-term multiple compression. Can 13-15% Procedure Growth in 2026 Sustain ISRG's Premium Valuation?
• Neutral Sentiment: Recent intraday moves included a modest rally that still underperformed broader markets, reflecting mixed investor positioning ahead of earnings. Intuitive Surgical, Inc. (ISRG) Advances But Underperforms Market: Key Facts
• Negative Sentiment: ISRG is down sharply YTD (near ~20% per coverage) as investors mark down the stock from a premium multiple amid concerns about near-term upside and broader macro pressures — a major factor driving today’s weakness. ISRG Stock Down Nearly 20% YTD: Should You Buy, Hold or Sell?
• Negative Sentiment: Erste Group (and related notes) trimmed FY estimates / has a weaker outlook for FY2027, signaling some analyst caution that could translate into lower near-term expectations. Erste Group Bank Has Weak Estimate for ISRG FY2027 Earnings

Insider Transactions at Intuitive Surgical

In related news, SVP Mark Brosius sold 645 shares of Intuitive Surgical stock in a transaction on Monday, March 9th. The stock was sold at an average price of $485.01, for a total value of $312,831.45. Following the completion of the sale, the senior vice president owned 1,613 shares of the company's stock, valued at $782,321.13. The trade was a 28.57% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Fredrik Widman sold 133 shares of the business's stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the sale, the vice president directly owned 660 shares of the company's stock, valued at $326,673.60. This represents a 16.77% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 32,943 shares of company stock worth $17,279,568. 0.60% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

Shares of ISRG opened at $450.65 on Monday. Intuitive Surgical, Inc. has a one year low of $427.84 and a one year high of $603.88. The firm has a market capitalization of $160.04 billion, a P/E ratio of 57.12, a PEG ratio of 3.52 and a beta of 1.68. The business has a fifty day moving average of $481.15 and a 200 day moving average of $514.65.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. During the same quarter in the previous year, the company posted $2.21 earnings per share. Intuitive Surgical's revenue was up 18.8% compared to the same quarter last year. Analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on ISRG shares. Argus lowered their price objective on Intuitive Surgical from $630.00 to $560.00 and set a "buy" rating for the company in a research note on Wednesday, February 4th. TD Cowen upgraded Intuitive Surgical to a "strong-buy" rating in a research note on Tuesday, January 27th. Evercore lowered their price objective on Intuitive Surgical from $550.00 to $480.00 and set a "neutral" rating for the company in a research note on Monday, April 6th. Citigroup upgraded Intuitive Surgical from a "neutral" rating to a "buy" rating and set a $590.00 price objective for the company in a research note on Wednesday, March 11th. Finally, Weiss Ratings restated a "hold (c+)" rating on shares of Intuitive Surgical in a research note on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $607.00.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.